Latest Breaking News On - Zyversa therapeutics - Page 5 : comparemela.com

ZyVersa Therapeutics (ZVSA) Reports Peer-Reviewed Article Supporting the Therapeutic Potential of Targeting ASC Specks During Progression of Alzheimer s Disease

ZyVersa Therapeutics (ZVSA) Reports Peer-Reviewed Article Supporting the Therapeutic Potential of Targeting ASC Specks During Progression of Alzheimer s Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRobertw keaneReginat vontellStephenc gloverResearch assistant professorUniversity of miami miller school medicineTranslational research clinical interventionsBrain endowment bankZyversa therapeutics incZyversa therapeuticsTranslational researchAssociate directorMiami miller schoolNeurological surgeryInflammatory disease scientific advisoryClinical interventions

ZyVersa Therapeutics (ZVSA) Reports Publication Linking Inflammasome Activation to Triple-Negative Breast Cancer Brain Metastasis

ZyVersa Therapeutics (ZVSA) Reports Publication Linking Inflammasome Activation to Triple-Negative Breast Cancer Brain Metastasis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Stephenc gloverZyversa therapeutics incActa neuropathologica communicationsZyversa therapeutics

ZyVersa Therapeutics Highlights Peer-Reviewed Article

NLRP3 Inflammasome Activation Is Linked to Brain Metastasis in Patients with Triple-Negative Breast Cancer. .

Casey mcdonaldDave schemeliaStephenc gloverZyversa therapeutics incActa neuropathologica communicationsSecurities exchangeVersa therapeuticsZyversa therapeuticsCholesterol efflux mediatorSecurities exchange actPrivate securities litigation reform actNasdaq zvsaZyversa therapeuticsTriple negative breast cancerBrain metastasisInflammasome activation

ZyVersa Therapeutics CEO, Stephen C Glover, Featured on Benzinga All Access

ZyVersa Therapeutics CEO, Stephen C Glover, Featured on Benzinga All Access
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Casey mcdonaldDave schemeliaStephenc gloverSecurities exchangeZyversa therapeutics incExchange commissionVersa therapeuticsChief executive officerBenzinga allCholesterol effluxInvestigational new drugZyversa therapeuticsSecurities exchange actPrivate securities litigation reform actAnnual reportQuarterly reports

ZyVersa Therapeutics CEO, Stephen C Glover, Issues Letter

WESTON, Fla., Jan. 03, 2024 (GLOBE NEWSWIRE) ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical.

Dave schemeliaCasey mcdonaldStephenc gloverZyversa therapeutics incSecurities exchangeExchange commissionVersa therapeuticsChief executive officerCholesterol effluxZyversa therapeuticsSecurities exchange actPrivate securities litigation reform actAnnual reportQuarterly reportsNasdaq zvsaZyversa therapeutics